BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 15, Issue 23
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (6824)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.
Item 
Count 
PDF610
HTML5922
Figures (1-1)150
Tables (1-4)142
 Sum=6824
Jun 21, 2009 (publication date) through May 6, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Kerckhoffs AP, Samsom M, van der Rest ME, de Vogel J, Knol J, Ben-Amor K, Akkermans LM. Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol 2009; 15(23): 2887-2892 [PMID: 19533811 DOI: 10.3748/wjg.15.2887]
URL: https://www.wjgnet.com/1007-9327/full/v15/i23/2887.htm
Number Citing Articles
1
Eoin Barrett, A K Deshpandey, C A Ryan, Eugene M Dempsey, Brendan Murphy, L O'Sullivan, C Watkins, R Paul Ross, Paul W O'Toole, Gerald F Fitzgerald, Catherine Stanton. The neonatal gut harbours distinct bifidobacterial strains. Archives of Disease in Childhood - Fetal and Neonatal Edition 2015; 100(5): F405 doi: 10.1136/archdischild-2014-306110
2
Daisuke Anzawa, Takashi Mawatari, Yoshiyuki Tanaka, Mio Yamamoto, Tomomi Genda, Shota Takahashi, Tomohiko Nishijima, Hiroshi Kamasaka, Satoru Suzuki, Takashi Kuriki. Effects of synbiotics containing Bifidobacterium animalis subsp. lactis GCL2505 and inulin on intestinal bifidobacteria: A randomized, placebo‐controlled, crossover study. Food Science & Nutrition 2019; 7(5): 1828 doi: 10.1002/fsn3.1033
3
Hamed Ebrahimzadeh Leylabadlo, Fatemah Sadeghpour Heravi, Elghar Soltani, Amin Abbasi, Hossein Samadi Kafil, Mahdi Parsaei, Sarvin Sanaie, Zainab Ahmadian, Reza Ghotaslou. The role of gut microbiota in the treatment of irritable bowel syndrome. Reviews in Medical Microbiology 2022; 33(1): e89 doi: 10.1097/MRM.0000000000000284
4
Yoonjin Nam, Young Sil Min, Uy Dong Sohn. Recent advances in pharmacological research on the management of irritable bowel syndrome. Archives of Pharmacal Research 2018; 41(10): 955 doi: 10.1007/s12272-018-1068-5
5
Pei Pei Chong, Voon Kin Chin, Chung Yeng Looi, Won Fen Wong, Priya Madhavan, Voon Chen Yong. The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.01136
6
Caoimhe M. K. Lynch, Kenneth J. O’Riordan, Gerard Clarke, John F. Cryan. Clinical Understanding of the Human Gut Microbiome. 2023; : 33 doi: 10.1007/978-3-031-46712-7_4
7
R. Singh, M. Nieuwdorp, I.J.M. ten Berge, F.J. Bemelman, S.E. Geerlings. The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection. Clinical Microbiology and Infection 2014; 20(11): 1119 doi: 10.1111/1469-0691.12799
8
Wenting Wen, Haibo Zhang, Junlong Shen, Luxia Wei, Shunong Shen. Fecal microbiota transplantation for patients with irritable bowel syndrome. Medicine 2018; 97(40): e12661 doi: 10.1097/MD.0000000000012661
9
Prashant Singh, Anthony Lembo. Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome. Gastroenterology Clinics of North America 2021; 50(3): 523 doi: 10.1016/j.gtc.2021.03.003
10
Arpita Aditya, Catherine Galleher, Yeal Ad, Mitchell Coburn, Aaron Zweig. Gut Microbiome and Its Impact on Health and Diseases. 2020; : 133 doi: 10.1007/978-3-030-47384-6_6
11
C. Chassard, M. Dapoigny, K. P. Scott, L. Crouzet, C. Del'homme, P. Marquet, J. C. Martin, G. Pickering, D. Ardid, A. Eschalier, C. Dubray, H. J. Flint, A. Bernalier‐Donadille. Functional dysbiosis within the gut microbiota of patients with constipated‐irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 2012; 35(7): 828 doi: 10.1111/j.1365-2036.2012.05007.x
12
Mark Pimentel, Anthony Lembo. Microbiome and Its Role in Irritable Bowel Syndrome. Digestive Diseases and Sciences 2020; 65(3): 829 doi: 10.1007/s10620-020-06109-5
13
Nikhil Aggarwal, Shohei Kitano, Ginette Ru Ying Puah, Sandra Kittelmann, In Young Hwang, Matthew Wook Chang. Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies. Chemical Reviews 2023; 123(1): 31 doi: 10.1021/acs.chemrev.2c00431
14
Shyam Vedantam, Erica Graff, Nabiha Shabbir Khakoo, Nidah Shabbir Khakoo, Michelle Pearlman. Food as Medicine: How to Influence the Microbiome and Improve Symptoms in Patients with Irritable Bowel Syndrome. Current Gastroenterology Reports 2023; 25(3): 52 doi: 10.1007/s11894-023-00861-0
15
Jing Cheng, Airi M. Palva, Willem M. de Vos, Reetta Satokari. Between Pathogenicity and Commensalism. Current Topics in Microbiology and Immunology 2011; 358: 323 doi: 10.1007/82_2011_189
16
Erin R. Shanahan, Ayesha Shah, Natasha Koloski, Marjorie M. Walker, Nicholas J. Talley, Mark Morrison, Gerald J. Holtmann. Influence of cigarette smoking on the human duodenal mucosa-associated microbiota. Microbiome 2018; 6(1) doi: 10.1186/s40168-018-0531-3
17
Heidi M. Staudacher, Miranda C.E. Lomer, Jacqueline L. Anderson, Jacqueline S. Barrett, Jane G. Muir, Peter M. Irving, Kevin Whelan. Fermentable Carbohydrate Restriction Reduces Luminal Bifidobacteria and Gastrointestinal Symptoms in Patients with Irritable Bowel Syndrome. The Journal of Nutrition 2012; 142(8): 1510 doi: 10.3945/jn.112.159285
18
Paul J Kennedy, John F Cryan, Timothy G Dinan, Gerard Clarke. Irritable bowel syndrome: A microbiome-gut-brain axis disorder?. World Journal of Gastroenterology 2014; 20(39): 14105-14125 doi: 10.3748/wjg.v20.i39.14105
19
Simone Maccaferri, Marco Candela, Silvia Turroni, Manuela Centanni, Marco Severgnini, Clarissa Consolandi, Piero Cavina, Patrizia Brigidi. IBS-associated phylogenetic unbalances of the intestinal microbiota are not reverted by probiotic supplementation. Gut Microbes 2012; 3(5): 406 doi: 10.4161/gmic.21009
20
Leonilde Bonfrate, Jan Tack, Ignazio Grattagliano, Rosario Cuomo, Piero Portincasa. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Scandinavian Journal of Gastroenterology 2013; 48(9): 995 doi: 10.3109/00365521.2013.799220
21
Sun-Young Kook, Yunjeong Kim, Ben Kang, Yon Ho Choe, Young-Ho Kim, Seokjin Kim. Characterization of the fecal microbiota differs between age groups in Koreans. Intestinal Research 2018; 16(2): 246 doi: 10.5217/ir.2018.16.2.246
22
Tyler Brown, Majid Bani-Yaghoub, Jose F. García-Mazcorro. Understanding the Competitive and Cooperative Interactions between Probiotics and Autochthonous Intestinal Bacteria. Journal of Biosciences and Medicines 2017; 5(04): 63 doi: 10.4236/jbm.2017.54007
23
Lucinda A. Harris, Noemi Baffy. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome. Postgraduate Medicine 2017; 129(8): 872 doi: 10.1080/00325481.2017.1383819
24
Laetitia Rodes, Arghya Paul, Michael Coussa-Charley, Hani Al-Salami, Catherine Tomaro-Duchesneau, Marc Fakhoury, Satya Prakash. Transit Time Affects the Community Stability ofLactobacillusandBifidobacteriumSpecies in anIn VitroModel of Human Colonic Microbiotia. Artificial Cells, Blood Substitutes, and Biotechnology 2011; 39(6): 351 doi: 10.3109/10731199.2011.622280
25
Kelton Tremellen, Karma Pearce. Dysbiosis of Gut Microbiota (DOGMA) – A novel theory for the development of Polycystic Ovarian Syndrome. Medical Hypotheses 2012; 79(1): 104 doi: 10.1016/j.mehy.2012.04.016
26
Faith D. Ihekweazu, Tatiana Y. Fofanova, Karen Queliza, Dorottya Nagy-Szakal, Christopher J. Stewart, Melinda A. Engevik, Kristina G. Hulten, Nina Tatevian, David Y. Graham, James Versalovic, Joseph F. Petrosino, Richard Kellermayer. Bacteroides ovatus ATCC 8483 monotherapy is superior to traditional fecal transplant and multi-strain bacteriotherapy in a murine colitis model. Gut Microbes 2019; 10(4): 504 doi: 10.1080/19490976.2018.1560753
27
Haihua Liu, Huiying Liu, Chang Liu, Mengxue Shang, Tianfu Wei, Peiyuan Yin. Gut Microbiome and the Role of Metabolites in the Study of Graves’ Disease. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.841223
28
Yan Xu, Ru Yao, Wenxue Zhao, Jianguo Zhu, Jingchun Yao, Guimin Zhang, Dongguang Liu. Spirocyclopiperazinium salt compound DXL-A-24 improves visceral sensation and gut microbiota in a rat model of irritable bowel syndrome. Heliyon 2023; 9(6): e16544 doi: 10.1016/j.heliyon.2023.e16544
29
Tong Xu, Ruijie Sun, Yuchen Zhang, Chen Zhang, Yujing Wang, Zhuo A. Wang, Yuguang Du. Recent Research and Application Prospect of Functional Oligosaccharides on Intestinal Disease Treatment. Molecules 2022; 27(21): 7622 doi: 10.3390/molecules27217622
30
F. Azpiroz, C. Dubray, A. Bernalier‐Donadille, J.‐M. Cardot, A. Accarino, J. Serra, A. Wagner, F. Respondek, M. Dapoigny. Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double blind, placebo controlled study. Neurogastroenterology & Motility 2017; 29(2) doi: 10.1111/nmo.12911
31
Ayesha Shah, Gerald Holtmann. Gastrointestinal Diseases and their Associated Infections. 2019; : 67 doi: 10.1016/B978-0-323-54843-4.00006-4
32
Elena Layunta, Berta Buey, Jose Emilio Mesonero, Eva Latorre. Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota–Gut–Brain Axis. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.748254
33
Mirjana Rajilić-Stojanović, Daisy M Jonkers, Anne Salonen, Kurt Hanevik, Jeroen Raes, Jonna Jalanka, Willem M de Vos, Chaysavanh Manichanh, Natasa Golic, Paul Enck, Elena Philippou, Fuad A Iraqi, Gerard Clarke, Robin C Spiller, John Penders. Intestinal Microbiota And Diet in IBS: Causes, Consequences, or Epiphenomena?. American Journal of Gastroenterology 2015; 110(2): 278 doi: 10.1038/ajg.2014.427
34
Lotanna Umeano, Sadaf Iftikhar, Sarah F Alhaddad, Christian N Paulsingh, Muhammad Faisal Riaz, Gourav Garg, Lubna Mohammed. Effectiveness of Probiotic Use in Alleviating Symptoms of Irritable Bowel Syndrome: A Systematic Review. Cureus 2024;  doi: 10.7759/cureus.58306
35
Ibrahim Masoodi, Ali S Alshanqeeti, Essam J Alyamani, Abed A AlLehibi, Adel N Alqutub, Khalid N Alsayari, Ahmed O Alomair. Microbial dysbiosis in irritable bowel syndrome: A single‐center metagenomic study in Saudi Arabia. JGH Open 2020; 4(4): 649 doi: 10.1002/jgh3.12313
36
Gangping Li, Min Yang, Yu Jin, Ying Li, Wei Qian, Hanhua Xiong, Jun Song, Xiaohua Hou. Involvement of shared mucosal‐associated microbiota in the duodenum and rectum in diarrhea‐predominant irritable bowel syndrome. Journal of Gastroenterology and Hepatology 2018; 33(6): 1220 doi: 10.1111/jgh.14059
37
Chang Kyo Oh, Jae Keun Park, Yu Jin Kim, Jin Bae Kim. Efficacy and safety of human gut-derived multi-strain probiotics in patients with irritable bowel syndrome: A prospective open-label observation study. Medicine 2023; 102(34): e34899 doi: 10.1097/MD.0000000000034899
38
Julia König, Ignacio Rangel, Robert J. Brummer. The Role of Lactic Acid Bacteria in the Pathophysiology and Treatment of Irritable Bowel Syndrome (IBS). Food and Nutrition Sciences 2013; 4(11): 27 doi: 10.4236/fns.2013.411A005
39
Gustavo D Pimentel, Thayana O Micheletti, Fernanda Pace, José C Rosa, Ronaldo VT Santos, Fabio S Lira. Gut-central nervous system axis is a target for nutritional therapies. Nutrition Journal 2012; 11(1) doi: 10.1186/1475-2891-11-22
40
Verena Grimm, Christina Westermann, Christian U. Riedel. Bifidobacteria-Host Interactions—An Update on Colonisation Factors. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/960826
41
Stéphanie Da Silva, Catherine Robbe-Masselot, Arthur Raymond, Myriam Mercade-Loubière, Christel Salvador-Cartier, Bélinda Ringot, Renaud Léonard, Isabelle Fourquaux, Afifa Ait-Belgnaoui, Pascal Loubière, Vassilia Théodorou, Muriel Mercier-Bonin, Wenke Feng. Spatial Localization and Binding of the Probiotic Lactobacillus farciminis to the Rat Intestinal Mucosa: Influence of Chronic Stress. PLOS ONE 2015; 10(9): e0136048 doi: 10.1371/journal.pone.0136048
42
Ratnakar Shukla, Ujjala Ghoshal, Prabhat Ranjan, Uday C Ghoshal. Expression of Toll-like Receptors, Pro-, and Anti-inflammatory Cytokines in Relation to Gut Microbiota in Irritable Bowel Syndrome: The Evidence for Its Micro-organic Basis. Journal of Neurogastroenterology and Motility 2018; 24(4): 628 doi: 10.5056/jnm18130
43
Rafael Tojo, Adolfo Suárez, Marta G Clemente, Clara G de los Reyes-Gavilán, Abelardo Margolles, Miguel Gueimonde, Patricia Ruas-Madiedo. Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis. World Journal of Gastroenterology 2014; 20(41): 15163-15176 doi: 10.3748/wjg.v20.i41.15163
44
Michele Teodoro, Federica Giambò. Well-Being and Safety in the Workplace. International Journal of Environmental Research and Public Health 2022; 19(14): 8712 doi: 10.3390/ijerph19148712
45
Minyu Song, Won Seo Park, Jayeon Yoo, Jun-Sang Ham. A Review on Bifidobacteria for Human Health. Journal of Milk Science and Biotechnology 2017; 35(2): 73 doi: 10.22424/jmsb.2017.35.2.73
46
Barbara Skrzydło-Radomańska, Beata Prozorow-Król, Halina Cichoż-Lach, Emilia Majsiak, Joanna B. Bierła, Wojciech Kosikowski, Mariusz Szczerbiński, Jesper Gantzel, Bożena Cukrowska. The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome—A Randomized Double-Blind, Placebo-Controlled Study. Nutrients 2020; 12(7): 1999 doi: 10.3390/nu12071999
47
Hannah Mitchell, Judi Porter, Peter R. Gibson, Jacqueline Barrett, Mayur Garg. Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome—directions for future research. Alimentary Pharmacology & Therapeutics 2019; 49(2): 124 doi: 10.1111/apt.15079
48
Verena Grimm, Christian U. Riedel. Microbiota of the Human Body. Advances in Experimental Medicine and Biology 2016; 902: 109 doi: 10.1007/978-3-319-31248-4_8
49
Arthur J. Kastl, Natalie A. Terry, Gary D Wu, Lindsey G. Albenberg. The Structure and Function of the Human Small Intestinal Microbiota: Current Understanding and Future Directions. Cellular and Molecular Gastroenterology and Hepatology 2020; 9(1): 33 doi: 10.1016/j.jcmgh.2019.07.006
50
Daniel Pohl, Stephan Vavricka, Mark Fox, Ahmed Madisch, Diana Studerus, Paul Wiesel, Henriette Heinrich, Ioannis Linas, Alain Schoepfer, Alexandra Schwizer, Stephan Wildi. Häufige Magen-Darm-Beschwerden: Management der funktionellen Dyspepsie und des Reizdarm-Syndroms in der Praxis. Praxis 2023; 112(5-6): 304 doi: 10.1024/1661-8157/a003988
51
Mohd Fyzal Bahrudin, Rafiz Abdul Rani, Azmi Mohd Tamil, Norfilza Mohd Mokhtar, Raja Affendi Raja Ali. Effectiveness of Sterilized Symbiotic Drink Containing Lactobacillus helveticus Comparable to Probiotic Alone in Patients with Constipation-Predominant Irritable Bowel Syndrome. Digestive Diseases and Sciences 2020; 65(2): 541 doi: 10.1007/s10620-019-05695-3
52
M. A. Livzan, O. V. Gaus. Modulation of microbiota as a target in the management of patients with irritable bowel syndrome. Meditsinskiy sovet = Medical Council 2023; (18): 18 doi: 10.21518/ms2023-366
53
Sarah L. Hagerty, Jarrod M. Ellingson, Timothy B. Helmuth, L. Cinnamon Bidwell, Kent E. Hutchison, Angela D. Bryan. An Overview and Proposed Research Framework for Studying Co-Occurring Mental- and Physical-Health Dysfunction. Perspectives on Psychological Science 2019; 14(4): 633 doi: 10.1177/1745691619827010
54
Heidi M. Staudacher, Kevin Whelan. Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet. Proceedings of the Nutrition Society 2016; 75(3): 306 doi: 10.1017/S0029665116000021
55
Francesca Romana Ponziani, Silvia Pecere, Loris Lopetuso, Franco Scaldaferri, Giovanni Cammarota, Antonio Gasbarrini. Rifaximin for the treatment of irritable bowel syndrome – a drug safety evaluation. Expert Opinion on Drug Safety 2016; 15(7): 983 doi: 10.1080/14740338.2016.1186639
56
Cristina M. SABO, Dan L. DUMITRASCU. Microbiota and the irritable bowel syndrome. Minerva Gastroenterology 2022; 67(4) doi: 10.23736/S2724-5985.21.02923-5
57
Marcela Julio-Pieper, Peter J. Flor, Timothy G. Dinan, John F. Cryan, David R. Sibley. Exciting Times beyond the Brain: Metabotropic Glutamate Receptors in Peripheral and Non-Neural Tissues. Pharmacological Reviews 2011; 63(1): 35 doi: 10.1124/pr.110.004036
58
K. J. Lee, J. Tack. Altered intestinal microbiota in irritable bowel syndrome. Neurogastroenterology & Motility 2010; 22(5): 493 doi: 10.1111/j.1365-2982.2010.01482.x
59
Kirsty Brown, Daniella DeCoffe, Erin Molcan, Deanna L. Gibson. Diet-Induced Dysbiosis of the Intestinal Microbiota and the Effects on Immunity and Disease. Nutrients 2012; 4(8): 1095 doi: 10.3390/nu4081095
60
Laura Rigsbee, Richard Agans, Vijay Shankar, Harshavardhan Kenche, Harry J Khamis, Sonia Michail, Oleg Paliy. Quantitative Profiling of Gut Microbiota of Children With Diarrhea-Predominant Irritable Bowel Syndrome. American Journal of Gastroenterology 2012; 107(11): 1740 doi: 10.1038/ajg.2012.287
61
Emma Elison, Louise K. Vigsnaes, Laura Rindom Krogsgaard, Julie Rasmussen, Nikolaj Sørensen, Bruce McConnell, Thierry Hennet, Morten O. A. Sommer, Peter Bytzer. Oral supplementation of healthy adults with 2′-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota. British Journal of Nutrition 2016; 116(8): 1356 doi: 10.1017/S0007114516003354
62
Hiroyasu Akatsu, Shinya Nagafuchi, Rina Kurihara, Kenji Okuda, Takeshi Kanesaka, Norihiro Ogawa, Takayoshi Kanematsu, Satoshi Takasugi, Taketo Yamaji, Masao Takami, Takayuki Yamamoto, Hirotaka Ohara, Mitsuo Maruyama. Enhanced vaccination effect against influenza by prebiotics in elderly patients receiving enteral nutrition. Geriatrics & Gerontology International 2016; 16(2): 205 doi: 10.1111/ggi.12454
63
Xiaomei Cong, Mallory Perry, Katherine M. Bernier, Erin E. Young, Angela Starkweather. Effects of Self-Management Interventions in Patients With Irritable Bowel Syndrome: Systematic Review. Western Journal of Nursing Research 2018; 40(11): 1698 doi: 10.1177/0193945917727705
64
Miguel Saps, Adrian Miranda. Gastrointestinal Pharmacology. Handbook of Experimental Pharmacology 2017; 239: 147 doi: 10.1007/164_2016_119
65
Eamonn M.M. Quigley. Small intestinal bacterial overgrowth. Current Opinion in Gastroenterology 2014; 30(2): 141 doi: 10.1097/MOG.0000000000000040
66
Melinda A. Engevik, Lori D. Banks, Kristen A. Engevik, Alexandra L. Chang-Graham, Jacob L. Perry, Diane S. Hutchinson, Nadim J. Ajami, Joseph F. Petrosino, Joseph M. Hyser. Rotavirus infection induces glycan availability to promote ileum-specific changes in the microbiome aiding rotavirus virulence. Gut Microbes 2020; 11(5): 1324 doi: 10.1080/19490976.2020.1754714
67
Eamonn M.M. Quigley. Commensal bacteria. Current Opinion in Clinical Nutrition and Metabolic Care 2011; 14(5): 497 doi: 10.1097/MCO.0b013e328348c033
68
Liyou Dong, Renata M.C. Ariëns, Antoine H.P. America, Aman Paul, Teun Veldkamp, Jurriaan J. Mes, Harry J. Wichers, Coen Govers. Clostridium perfringens suppressing activity in black soldier fly protein preparations. LWT 2021; 149: 111806 doi: 10.1016/j.lwt.2021.111806
69
Marta Pozuelo, Suchita Panda, Alba Santiago, Sara Mendez, Anna Accarino, Javier Santos, Francisco Guarner, Fernando Azpiroz, Chaysavanh Manichanh. Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome. Scientific Reports 2015; 5(1) doi: 10.1038/srep12693
70
Magdy El-Salhy, Tarek Mazzawi. Fecal microbiota transplantation for managing irritable bowel syndrome. Expert Review of Gastroenterology & Hepatology 2018; 12(5): 439 doi: 10.1080/17474124.2018.1447380
71
Jennifer L. Owen, Mansour Mohamadzadeh. Microbial Activation of Gut Dendritic Cells and the Control of Mucosal Immunity. Journal of Interferon & Cytokine Research 2013; 33(11): 619 doi: 10.1089/jir.2013.0046
72
Ana Durbán, Juan J. Abellán, Nuria Jiménez‐Hernández, Patricia Salgado, Marta Ponce, Julio Ponce, Vicente Garrigues, Amparo Latorre, Andrés Moya. Structural alterations of faecal and mucosa‐associated bacterial communities in irritable bowel syndrome. Environmental Microbiology Reports 2012; 4(2): 242 doi: 10.1111/j.1758-2229.2012.00327.x
73
Hwaebong Jung, Junho Hwang, Yong-Sahm Choe, Hyun-Sook Lee, Wooyoung Lee. Highly Sensitive and Selective Detection of Hydrogen Using Pd-Coated SnO2 Nanorod Arrays for Breath-Analyzer Applications. Sensors 2022; 22(5): 2056 doi: 10.3390/s22052056
74
Aref Shariati, Fateme Fallah, Ali Pormohammad, Ali Taghipour, Hossein Safari, Alireza salami chirani, Sahar Sabour, Mahmood Alizadeh‐Sani, Taher Azimi. The possible role of bacteria, viruses, and parasites in initiation and exacerbation of irritable bowel syndrome. Journal of Cellular Physiology 2019; 234(6): 8550 doi: 10.1002/jcp.27828
75
Fatemah Sadeghpour Heravi. Gut Microbiota and Autoimmune Diseases: Mechanisms, Treatment, Challenges, and Future Recommendations. Current Clinical Microbiology Reports 2024; 11(1): 18 doi: 10.1007/s40588-023-00213-6
76
Patricia Sanz Morales, Anisha Wijeyesekera, Margaret Denise Robertson, Peter P. J. Jackson, Glenn R. Gibson. The Potential Role of Human Milk Oligosaccharides in Irritable Bowel Syndrome. Microorganisms 2022; 10(12): 2338 doi: 10.3390/microorganisms10122338
77
Peter Layer. Handbuch Gastroenterologie 2010. 2010; : 303 doi: 10.1007/978-3-642-11635-3_9
78
Z. Liang, N. Di, L. Li, D. Yang. Gut microbiota alterations reveal potential gut–brain axis changes in polycystic ovary syndrome. Journal of Endocrinological Investigation 2021; 44(8): 1727 doi: 10.1007/s40618-020-01481-5
79
Silvia Arboleya, Claire Watkins, Catherine Stanton, R. Paul Ross. Gut Bifidobacteria Populations in Human Health and Aging. Frontiers in Microbiology 2016; 7 doi: 10.3389/fmicb.2016.01204
80
Parth J Parekh, Luis A Balart, David A Johnson. The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease. Clinical and Translational Gastroenterology 2015; 6(6): e91 doi: 10.1038/ctg.2015.16
81
W.-T. Fan, C. Ding, N.-N. Xu, S. Zong, P. Ma, B. Gu. Close association between intestinal microbiota and irritable bowel syndrome. European Journal of Clinical Microbiology & Infectious Diseases 2017; 36(12): 2303 doi: 10.1007/s10096-017-3060-2
82
Ruchi Mathur, Kathleen S. Chua, Mindy Mamelak, Walter Morales, Gillian M. Barlow, Rita Thomas, Darko Stefanovski, Stacy Weitsman, Zachary Marsh, Richard N. Bergman, Mark Pimentel. Metabolic effects of eradicating breath methane using antibiotics in prediabetic subjects with obesity. Obesity 2016; 24(3): 576 doi: 10.1002/oby.21385
83
M. M. Walker, N. J. Talley. Review article: bacteria and pathogenesis of disease in the upper gastrointestinal tract – beyond the era of Helicobacter pylori. Alimentary Pharmacology & Therapeutics 2014; 39(8): 767 doi: 10.1111/apt.12666
84
Uday C. Ghoshal, Ratnakar Shukla, Ujjala Ghoshal, Kok-Ann Gwee, Siew C. Ng, Eamonn M. M. Quigley. The Gut Microbiota and Irritable Bowel Syndrome: Friend or Foe?. International Journal of Inflammation 2012; 2012: 1 doi: 10.1155/2012/151085
85
Jun Sik Yoon, Won Sohn, Oh Young Lee, Sang Pyo Lee, Kang Nyeong Lee, Dae Won Jun, Hang Lak Lee, Byung Chul Yoon, Ho Soon Choi, Won‐Seok Chung, Jae‐Gu Seo. Effect of multispecies probiotics on irritable bowel syndrome: A randomized, double‐blind, placebo‐controlled trial. Journal of Gastroenterology and Hepatology 2014; 29(1): 52 doi: 10.1111/jgh.12322
86
Phoebe E. Heenan, Jacqueline I. Keenan, Simone Bayer, Myrthe Simon, Richard B. Gearry. Irritable bowel syndrome and the gut microbiota. Journal of the Royal Society of New Zealand 2020; 50(3): 470 doi: 10.1080/03036758.2019.1695635
87
Jareth Jun Jie Ng, Wai Mun Loo, Kewin Tien Ho Siah. Associations between irritable bowel syndrome and non-alcoholic fatty liver disease: A systematic review. World Journal of Hepatology 2023; 15(7): 925-938 doi: 10.4254/wjh.v15.i7.925
88
Barbara Skrzydło-Radomańska, Beata Prozorow-Król, Anetta Kurzeja-Mirosław, Halina Cichoż-Lach, Katarzyna Laskowska, Emilia Majsiak, Joanna B. Bierła, Sowińska Agnieszka, Bożena Cukrowska. The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in Adult Patients with Irritable Bowel Syndrome—A Randomized Double-Blind Placebo-Controlled Three-Arm Interventional Trial. Journal of Clinical Medicine 2023; 12(14): 4838 doi: 10.3390/jcm12144838
89
M. Pimentel. Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea. Alimentary Pharmacology & Therapeutics 2016; 43(S1): 37 doi: 10.1111/apt.13437
90
Yehuda Ringel, Nitsan Maharshak. Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. American Journal of Physiology-Gastrointestinal and Liver Physiology 2013; 305(8): G529 doi: 10.1152/ajpgi.00207.2012
91
Karolina Skonieczna-Żydecka, Igor Loniewski, Anastasios Koulaouzidis, Wojciech Marlicz. Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications. 2019; : 251 doi: 10.1016/B978-0-12-815249-2.00026-9
92
Mark Pimentel, Christopher Chang. Inflammation and Microflora. Gastroenterology Clinics of North America 2011; 40(1): 69 doi: 10.1016/j.gtc.2010.12.010
93
David J. Wrigglesworth, Elisha Goonatilleke, Richard Haydock, Kevin R. Hughes, Carlito B. Lebrilla, Kelly S. Swanson, Paul Jones, Phillip Watson, Joseph Banoub. High-throughput glycomic analyses reveal unique oligosaccharide profiles of canine and feline milk samples. PLOS ONE 2020; 15(12): e0243323 doi: 10.1371/journal.pone.0243323
94
S. Guglielmetti, D. Mora, M. Gschwender, K. Popp. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life -- a double-blind, placebo-controlled study. Alimentary Pharmacology & Therapeutics 2011; 33(10): 1123 doi: 10.1111/j.1365-2036.2011.04633.x
95
I. W. Fong. The Role of Microbes in Common Non-Infectious Diseases. 2014; : 1 doi: 10.1007/978-1-4939-1670-2_1
96
Sean M.P. Bennet, Lena Ohman, Magnus Simren. Gut Microbiota as Potential Orchestrators of Irritable Bowel Syndrome. Gut and Liver 2015; 9(3) doi: 10.5009/gnl14344
97
Barbara Skrzydło-Radomańska, Beata Prozorow-Król, Halina Cichoż-Lach, Emilia Majsiak, Joanna Beata Bierła, Ewelina Kanarek, Agnieszka Sowińska, Bożena Cukrowska. The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study. Nutrients 2021; 13(3): 756 doi: 10.3390/nu13030756
98
Julian R. Marchesi, Sophie Allen, Emma Scott, Huw Jenkins, Claire Sadlier, Sian Thomas. An observational investigation of the faecal microbiota and metabonome of gastrostomy fed children, on blended and formula diets. Gut Microbes 2022; 14(1) doi: 10.1080/19490976.2022.2138661
99
Xue Shang, Fen-Fen E, Kang-Le Guo, Yan-Fei Li, Hong-Lin Zhao, Yan Wang, Nan Chen, Tao Nian, Chao-Qun Yang, Ke-Hu Yang, Xiu-Xia Li. Effectiveness and Safety of Probiotics for Patients with Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials. Nutrients 2022; 14(12): 2482 doi: 10.3390/nu14122482
100
Elizabeth K Brint, John MacSharry, Aine Fanning, Fergus Shanahan, Eamonn M M Quigley. Differential Expression of Toll-Like Receptors in Patients With Irritable Bowel Syndrome. American Journal of Gastroenterology 2011; 106(2): 329 doi: 10.1038/ajg.2010.438
101
Mark Pimentel, Ruchi Mathur, Christopher Chang. Gas and the Microbiome. Current Gastroenterology Reports 2013; 15(12) doi: 10.1007/s11894-013-0356-y
102
Michael C. Petriello, Jessie B. Hoffman, Olga Vsevolozhskaya, Andrew J. Morris, Bernhard Hennig. Dioxin-like PCB 126 increases intestinal inflammation and disrupts gut microbiota and metabolic homeostasis. Environmental Pollution 2018; 242: 1022 doi: 10.1016/j.envpol.2018.07.039
103
Agnieszka Krawczyk, Katarzyna Talaga-Ćwiertnia, Katarzyna Biegun, Kamil Drożdż, Dominika Salamon, Tomasz Gosiewski, Agnieszka Sroka-Oleksiak. Quantitative evaluation of the genus Bifidobacterium in stool samples of patients with type 1 and 2 diabetes. Postępy Higieny i Medycyny Doświadczalnej 2023; 77(1): 59 doi: 10.2478/ahem-2023-0007
104
Nirit Keren, Uri Gophna. Beneficial Microorganisms in Multicellular Life Forms. 2012; : 211 doi: 10.1007/978-3-642-21680-0_15
105
Paul Enck, Qasim Aziz, Giovanni Barbara, Adam D. Farmer, Shin Fukudo, Emeran A. Mayer, Beate Niesler, Eamonn M. M. Quigley, Mirjana Rajilić-Stojanović, Michael Schemann, Juliane Schwille-Kiuntke, Magnus Simren, Stephan Zipfel, Robin C. Spiller. Irritable bowel syndrome. Nature Reviews Disease Primers 2016; 2(1) doi: 10.1038/nrdp.2016.14
106
Sarah W. Matthews, Margaret M. Heitkemper, Kendra Kamp. Early Evidence Indicates Vitamin D Improves Symptoms of Irritable Bowel Syndrome. Gastroenterology Nursing 2021; 44(6): 426 doi: 10.1097/SGA.0000000000000634
107
Chunhua Zhou, Xue Fang, Jiajia Xu, Jun Gao, Ling Zhang, Jiulong Zhao, Yuting Meng, Wei Zhou, Xu Han, Yu Bai, Zhaoshen Li, Duowu Zou. Bifidobacterium longum alleviates irritable bowel syndrome-related visceral hypersensitivity and microbiota dysbiosis via Paneth cell regulation. Gut Microbes 2020; 12(1): 1782156 doi: 10.1080/19490976.2020.1782156
108
Qian Chen, Yiping Ren, Jihong Lu, Mark Bartlett, Lei Chen, Yan Zhang, Xiaokui Guo, Chang Liu. A Novel Prebiotic Blend Product Prevents Irritable Bowel Syndrome in Mice by Improving Gut Microbiota and Modulating Immune Response. Nutrients 2017; 9(12): 1341 doi: 10.3390/nu9121341
109
Janneke P. Ouwerkerk, Willem M. de Vos, Clara Belzer. Glycobiome: Bacteria and mucus at the epithelial interface. Best Practice & Research Clinical Gastroenterology 2013; 27(1): 25 doi: 10.1016/j.bpg.2013.03.001
110
Eleonora Distrutti, Lorenzo Monaldi, Patrizia Ricci, Stefano Fiorucci. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World Journal of Gastroenterology 2016; 22(7): 2219-2241 doi: 10.3748/wjg.v22.i7.2219
111
Kentaro Shimizu, Hiroshi Ogura, Toshimitsu Hamasaki, Miki Goto, Osamu Tasaki, Takashi Asahara, Koji Nomoto, Masami Morotomi, Asako Matsushima, Yasuyuki Kuwagata, Hisashi Sugimoto. Altered Gut Flora Are Associated with Septic Complications and Death in Critically Ill Patients with Systemic Inflammatory Response Syndrome. Digestive Diseases and Sciences 2011; 56(4): 1171 doi: 10.1007/s10620-010-1418-8
112
Jacoline Gerritsen, Hauke Smidt, Ger T. Rijkers, Willem M. de Vos. Intestinal microbiota in human health and disease: the impact of probiotics. Genes & Nutrition 2011; 6(3): 209 doi: 10.1007/s12263-011-0229-7
113
Bruno K. Rodiño-Janeiro, María Vicario, Carmen Alonso-Cotoner, Roberto Pascua-García, Javier Santos. A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies. Advances in Therapy 2018; 35(3): 289 doi: 10.1007/s12325-018-0673-5
114
Angèle P. M. Kerckhoffs, Kaouther Ben-Amor, Melvin Samsom, Michel E. van der Rest, Joris de Vogel, Jan Knol, Louis M. A. Akkermans. Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome.  Journal of Medical Microbiology 2011; 60(2): 236 doi: 10.1099/jmm.0.022848-0
115
Andrew R. Nafarin, Badriul Hegar, Hikari A. Sjakti, Yvan Vandenplas. Gut microbiome pattern in adolescents with functional gastrointestinal disease. International Journal of Pediatrics and Adolescent Medicine 2019; 6(1): 12 doi: 10.1016/j.ijpam.2019.01.005
116
Dachao Liang, Ross Ka-Kit Leung, Wenda Guan, William W. Au. Involvement of gut microbiome in human health and disease: brief overview, knowledge gaps and research opportunities. Gut Pathogens 2018; 10(1) doi: 10.1186/s13099-018-0230-4
117
Kazuhiko Ikeuchi, Takeya Tsutsumi, Aya Ishizaka, Taketoshi Mizutani, Ayako Sedohara, Michiko Koga, Satoru Tamaoki, Hiroshi Yotsuyanagi. Modulation of duodenal and jejunal microbiota by rifaximin in mice with CCl4-induced liver fibrosis. Gut Pathogens 2023; 15(1) doi: 10.1186/s13099-023-00541-4
118
John O’Grady, Fergus Shanahan. Dietary Fiber and Gastrointestinal Disease: an Evolving Story. Current Gastroenterology Reports 2018; 20(12) doi: 10.1007/s11894-018-0667-0
119
Emily K Stern, Darren M Brenner. Gut Microbiota-Based Therapies for Irritable Bowel Syndrome. Clinical and Translational Gastroenterology 2018; 9(2): e134 doi: 10.1038/ctg.2018.2
120
Legaki Evangelia, Eleni Anna Karanasou, Maria Gazouli. Gut Microbiome-Related Diseases and Therapies. The Microbiomes of Humans, Animals, Plants, and the Environment 2021; 1: 41 doi: 10.1007/978-3-030-59642-2_3
121
Nicola Principi, Rita Cozzali, Edoardo Farinelli, Andrea Brusaferro, Susanna Esposito. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics. Journal of Infection 2018; 76(2): 111 doi: 10.1016/j.jinf.2017.12.013
122
Magdy El-Salhy, Trygve Hausken, Jan Gunnar Hatlebakk. Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS). Nutrients 2019; 11(6): 1415 doi: 10.3390/nu11061415
123
Lena Öhman, Hans Törnblom, Magnus Simrén. Crosstalk at the mucosal border: importance of the gut microenvironment in IBS. Nature Reviews Gastroenterology & Hepatology 2015; 12(1): 36 doi: 10.1038/nrgastro.2014.200
124
Carine Nunes de Almada, Caroline Nunes de Almada, Rafael Chacon Ruiz Martinez, Anderson de Souza Sant’Ana. Characterization of the intestinal microbiota and its interaction with probiotics and health impacts. Applied Microbiology and Biotechnology 2015; 99(10): 4175 doi: 10.1007/s00253-015-6582-5
125
Caterina Carco, Wayne Young, Richard B. Gearry, Nicholas J. Talley, Warren C. McNabb, Nicole C. Roy. Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis. Frontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.00468
126
Hai-Ning Liu, Hao Wu, Yu-Zhuo Chen, Yan-Jie Chen, Xi-Zhong Shen, Tao-Tao Liu. Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis. Digestive and Liver Disease 2017; 49(4): 331 doi: 10.1016/j.dld.2017.01.142
127
Annamaria Altomare, Federica Del Chierico, Giulia Rocchi, Sara Emerenziani, Chiara Nuglio, Lorenza Putignani, Silvia Angeletti, Alessandra Lo Presti, Massimo Ciccozzi, Alessandra Russo, Silvia Cocca, Mentore Ribolsi, Maurizio Muscaritoli, Michele Cicala, Michele Pier Luca Guarino. Association between Dietary Habits and Fecal Microbiota Composition in Irritable Bowel Syndrome Patients: A Pilot Study. Nutrients 2021; 13(5): 1479 doi: 10.3390/nu13051479
128
Evangelos Giamarellos-Bourboulis, Jie Tang, Emmannouil Pyleris, Aikaterini Pistiki, Charalambos Barbatzas, Jordan Brown, Clarence C Lee, Timothy T Harkins, Gene Kim, Stacy Weitsman, Gillian M Barlow, Vincent A Funari, Mark Pimentel. Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome. Scandinavian Journal of Gastroenterology 2015; 50(9): 1076 doi: 10.3109/00365521.2015.1027261
129
Shengtao Zhu, Si Liu, Hengcun Li, Zheng Zhang, Qian Zhang, Lei Chen, Yu Zhao, Yang Chen, Junchao Gu, Li Min, Shutian Zhang. Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome. Frontiers in Cellular and Infection Microbiology 2019; 9 doi: 10.3389/fcimb.2019.00346
130
Helena Tlaskalova-Hogenova, Miloslav Kverka, Elena F. Verdu, Jerry M. Wells. Mucosal Immunology. 2015; : 109 doi: 10.1016/B978-0-12-415847-4.00008-2
131
Gillian M. Barlow, Allen Yu, Ruchi Mathur. Role of the Gut Microbiome in Obesity and Diabetes Mellitus. Nutrition in Clinical Practice 2015; 30(6): 787 doi: 10.1177/0884533615609896
132
K. V. Ivashkin, V. R. Grechishnikova, M. S. Reshetova, V. T. Ivashkin. Irritable Bowel and Bacterial Overgrowth Syndromes: a Bacterial Link Hypothesis of Functional Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2021; 31(1): 54 doi: 10.22416/1382-4376-2021-31-1-54-63
133
Heng-Li Niu, Ji-Yuan Xiao. The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials. International Journal of Surgery 2020; 75: 116 doi: 10.1016/j.ijsu.2020.01.142
134
N.M. Mokhtar, N.Md. Jaafar, E Alfian, N.D. Mohd Rathi, R Abdul Rani, R.A. Raja Ali. Clinical assessment and cytokines level in constipation-predominant irritable bowel syndrome participants treated with Lactobacillus-containing cultured milk drink. Acta Gastro Enterologica Belgica 2021; 84(4): 585 doi: 10.51821/84.4.009
135
Bo Deng, Jie Wu, Xiaohui Li, Xiaoming Men, Ziwei Xu. Probiotics and Probiotic Metabolic Product Improved Intestinal Function and Ameliorated LPS-Induced Injury in Rats. Current Microbiology 2017; 74(11): 1306 doi: 10.1007/s00284-017-1318-7
136
Amir Mari, Fadi Abu Baker, Mahmud Mahamid, Wisam Sbeit, Tawfik Khoury. The Evolving Role of Gut Microbiota in the Management of Irritable Bowel Syndrome: An Overview of the Current Knowledge. Journal of Clinical Medicine 2020; 9(3): 685 doi: 10.3390/jcm9030685
137
Paul D Cotter. Small intestine and microbiota. Current Opinion in Gastroenterology 2011; 27(2): 99 doi: 10.1097/MOG.0b013e328341dc67
138
T. H. Mertsalmi, V. T. E. Aho, P. A. B. Pereira, L. Paulin, E. Pekkonen, P. Auvinen, F. Scheperjans. More than constipation – bowel symptoms in Parkinson's disease and their connection to gut microbiota. European Journal of Neurology 2017; 24(11): 1375 doi: 10.1111/ene.13398
139
Sabina Mir, Richard Kellermayer, Ajay S. Gulati. Pediatric Fecal Microbiota Transplantation. Current Pediatrics Reports 2014; 2(3): 227 doi: 10.1007/s40124-014-0049-5
140
Mirjana Rajilić-Stojanović, Willem M. de Vos. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiology Reviews 2014; 38(5): 996 doi: 10.1111/1574-6976.12075
141
S.E. Richards, E. Holmes. Metabolomics as a Tool in Nutrition Research. 2015; : 17 doi: 10.1016/B978-1-78242-084-2.00002-2
142
Ying Chen, Shuiming Xiao, Zipeng Gong, Xiaoxin Zhu, Qing Yang, Yujie Li, Shuangrong Gao, Yu Dong, Zhe Shi, Yajie Wang, Xiaogang Weng, Qi Li, Weiyan Cai, Weijie Qiang. Wuji Wan Formula Ameliorates Diarrhea and Disordered Colonic Motility in Post-inflammation Irritable Bowel Syndrome Rats by Modulating the Gut Microbiota. Frontiers in Microbiology 2017; 8 doi: 10.3389/fmicb.2017.02307
143
Kai Zhan, Huan Zheng, Jianqing Li, Haomeng Wu, Shumin Qin, Lei Luo, Shaogang Huang, Loris Riccardo Lopetuso. Gut Microbiota-Bile Acid Crosstalk in Diarrhea-Irritable Bowel Syndrome. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/3828249
144
Magdy El‐Salhy. Intestinal bacteria associated with irritable bowel syndrome and chronic fatigue. Neurogastroenterology & Motility 2023; 35(9) doi: 10.1111/nmo.14621
145
J. König, R.J. Brummer. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome. Beneficial Microbes 2014; 5(3): 247 doi: 10.3920/BM2013.0033
146
Inna Sekirov, Shannon L. Russell, L. Caetano M. Antunes, B. Brett Finlay. Gut Microbiota in Health and Disease. Physiological Reviews 2010; 90(3): 859 doi: 10.1152/physrev.00045.2009
147
Hanna Fjeldheim Dale, Stella Hellgren Rasmussen, Özgün Ömer Asiller, Gülen Arslan Lied. Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review. Nutrients 2019; 11(9): 2048 doi: 10.3390/nu11092048
148
Xiaomei Cong, Divya Ramesh, Mallory Perry, Wanli Xu, Katherine M. Bernier, Erin E. Young, Stephen Walsh, Angela Starkweather. Pain self‐management plus nurse‐led support in young adults with irritable bowel syndrome: Study protocol for a pilot randomized control trial. Research in Nursing & Health 2018; 41(2): 121 doi: 10.1002/nur.21862
149
Erin D. Lewis, Joseph M. Antony, David C. Crowley, Amanda Piano, Renu Bhardwaj, Thomas A. Tompkins, Malkanthi Evans. Efficacy of Lactobacillus paracasei HA-196 and Bifidobacterium longum R0175 in Alleviating Symptoms of Irritable Bowel Syndrome (IBS): A Randomized, Placebo-Controlled Study. Nutrients 2020; 12(4): 1159 doi: 10.3390/nu12041159
150
Heidi M. Staudacher, Peter M. Irving, Miranda C. E. Lomer, Kevin Whelan. Mechanisms and efficacy of dietary FODMAP restriction in IBS. Nature Reviews Gastroenterology & Hepatology 2014; 11(4): 256 doi: 10.1038/nrgastro.2013.259
151
Suma S Magge, Jacqueline L Wolf. Complementary and Alternative Medicine and Mind–Body Therapies for Treatment of Irritable Bowel Syndrome in Women. Women's Health 2013; 9(6): 557 doi: 10.2217/WHE.13.57
152
Hye-kyung Jung, Nicholas J Talley. Role of the Duodenum in the Pathogenesis of Functional Dyspepsia: A Paradigm Shift. Journal of Neurogastroenterology and Motility 2018; 24(3): 345 doi: 10.5056/jnm18060
153
Yangfan Hou, Lei Dong, Xiaolan Lu, Haitao Shi, Bing Xu, Wenting Zhong, Lin Ma, Shuhui Wang, Caifeng Yang, Xinyi He, Yidi Zhao, Shenhao Wang. Distinctions Between Fecal and Intestinal Mucosal Microbiota in Subgroups of Irritable Bowel Syndrome. Digestive Diseases and Sciences 2022; 67(12): 5580 doi: 10.1007/s10620-022-07588-4
154
Yasunori Nakayama, Naoko Kawasaki, Taiga Tamiya, Sayuri Anzai, Kiyotsuna Toyohara, Akira Nishiyama, Eiichi Kitazono. Comparison of the prebiotic properties of native chicory and synthetic inulins using swine fecal cultures. Bioscience, Biotechnology, and Biochemistry 2020; 84(7): 1486 doi: 10.1080/09168451.2020.1749553
155
Tingting Su, Rongbei Liu, Allen Lee, Yanqin Long, Lijun Du, Sanchuan Lai, Xueqin Chen, Lan Wang, Jianmin Si, Chung Owyang, Shujie Chen. Altered Intestinal Microbiota with Increased Abundance of Prevotella Is Associated with High Risk of Diarrhea-Predominant Irritable Bowel Syndrome. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/6961783
156
L. Crouzet, E. Gaultier, C. Del'Homme, C. Cartier, E. Delmas, M. Dapoigny, J. Fioramonti, A. Bernalier‐Donadille. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota. Neurogastroenterology & Motility 2013; 25(4) doi: 10.1111/nmo.12103
157
Jessica R Biesiekierski, Jonna Jalanka, Heidi M Staudacher. Can Gut Microbiota Composition Predict Response to Dietary Treatments?. Nutrients 2019; 11(5): 1134 doi: 10.3390/nu11051134
158
Nitzan Koppel, Emily P. Balskus. Exploring and Understanding the Biochemical Diversity of the Human Microbiota. Cell Chemical Biology 2016; 23(1): 18 doi: 10.1016/j.chembiol.2015.12.008
159
G. C. Parkes, N. B. Rayment, B. N. Hudspith, L. Petrovska, M. C. Lomer, J. Brostoff, K. Whelan, J. D. Sanderson. Distinct microbial populations exist in the mucosa‐associated microbiota of sub‐groups of irritable bowel syndrome. Neurogastroenterology & Motility 2012; 24(1): 31 doi: 10.1111/j.1365-2982.2011.01803.x
160
Beom Jae Lee, Young-Tae Bak. Irritable Bowel Syndrome, Gut Microbiota and Probiotics. Journal of Neurogastroenterology and Motility 2011; 17(3): 252 doi: 10.5056/jnm.2011.17.3.252
161
Lena Öhman, Magnus Simrén. Intestinal Microbiota and its Role in Irritable Bowel Syndrome (IBS). Current Gastroenterology Reports 2013; 15(5) doi: 10.1007/s11894-013-0323-7
162
Bryan Tungland. Human Microbiota in Health and Disease. 2018; : 197 doi: 10.1016/B978-0-12-814649-1.00006-5
163
Michel Dapoigny. Irritable Bowel Syndrome. 2013; : 141 doi: 10.1002/9781118444689.ch8
164
Samantha K. Gill, Megan Rossi, Balazs Bajka, Kevin Whelan. Dietary fibre in gastrointestinal health and disease. Nature Reviews Gastroenterology & Hepatology 2021; 18(2): 101 doi: 10.1038/s41575-020-00375-4
165
Manon Defaye, Sandie Gervason, Christophe Altier, Jean-Yves Berthon, Denis Ardid, Edith Filaire, Frédéric Antonio Carvalho. Microbiota: a novel regulator of pain. Journal of Neural Transmission 2020; 127(4): 445 doi: 10.1007/s00702-019-02083-z
166
Phillipp Hartmann. Editorial: The Microbiome in Hepatobiliary and Intestinal Disease. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.893074
167
Emeran A. Mayer, Tor Savidge, Robert J. Shulman. Brain–Gut Microbiome Interactions and Functional Bowel Disorders. Gastroenterology 2014; 146(6): 1500 doi: 10.1053/j.gastro.2014.02.037
168
Anne Salonen, Willem M. de Vos, Airi Palva. Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology 2010; 156(11): 3205 doi: 10.1099/mic.0.043257-0
169
Julia König, Robert-Jan Brummer. Pharma-Nutrition. AAPS Advances in the Pharmaceutical Sciences Series 2014; 12: 55 doi: 10.1007/978-3-319-06151-1_4
170
Elena F Verdu. Editorial: Differences in Intestinal Microbial Composition in Children With IBS—What Does It All Mean?. American Journal of Gastroenterology 2012; 107(11): 1752 doi: 10.1038/ajg.2012.291
171
I. Qureshi, J.R. Endres. Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease. 2013; : 215 doi: 10.1016/B978-0-12-397154-8.00027-0
172
Ahmed E. Salem, Rajdeep Singh, Younan K. Ayoub, Ahmed M. Khairy, Gerard E. Mullin. The gut microbiome and irritable bowel syndrome: State of art review. Arab Journal of Gastroenterology 2018; 19(3): 136 doi: 10.1016/j.ajg.2018.02.008
173
Christian U. Riedel. The Bifidobacteria and Related Organisms. 2018; : 221 doi: 10.1016/B978-0-12-805060-6.00013-2
174
Pouyan Ghaffari, Saeed Shoaie, Lars K. Nielsen. Irritable bowel syndrome and microbiome; Switching from conventional diagnosis and therapies to personalized interventions. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03365-z
175
Ratnakar Shukla, Ujjala Ghoshal, Tapan N. Dhole, Uday C. Ghoshal. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis. Digestive Diseases and Sciences 2015; 60(10): 2953 doi: 10.1007/s10620-015-3607-y
176
Lemonica Koumbi, Olga Giouleme, Emilia Vassilopoulou. Non-Celiac Gluten Sensitivity and Irritable Bowel Disease: Looking for the Culprits. Current Developments in Nutrition 2020; 4(12): nzaa176 doi: 10.1093/cdn/nzaa176
177
Sim K. Singhrao, Sarita Robinson, Alice Harding. Trends in Personalized Nutrition. 2019; : 81 doi: 10.1016/B978-0-12-816403-7.00004-0
178
Beatriz Míguez, Carlos Vila, Koen Venema, Juan C. Parajó, José L. Alonso. Potential of High- and Low-Acetylated Galactoglucomannooligosaccharides as Modulators of the Microbiota Composition and Their Activity: A Comparison Using the In Vitro Model of the Human Colon TIM-2. Journal of Agricultural and Food Chemistry 2020; 68(29): 7617 doi: 10.1021/acs.jafc.0c02225
179
M. Schmulson, M.V. Bielsa, R. Carmona-Sánchez, A. Hernández, A. López-Colombo, Y. López Vidal, M. Peláez-Luna, J.M. Remes-Troche, J.L. Tamayo, M.A. Valdovinos. Microbiota, infecciones gastrointestinales, inflamación de bajo grado y antibioticoterapia en el síndrome de intestino irritable. Una revisión basada en evidencias. Revista de Gastroenterología de México 2014; 79(2): 96 doi: 10.1016/j.rgmx.2014.01.004
180
Dania Schumann, Petra Klose, Romy Lauche, Gustav Dobos, Jost Langhorst, Holger Cramer. Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: A systematic review and meta-analysis. Nutrition 2018; 45: 24 doi: 10.1016/j.nut.2017.07.004
181
Magdy El‐Salhy, Odd Helge Gilja, Jan Gunnar Hatlebakk. Factors affecting the outcome of fecal microbiota transplantation for patients with irritable bowel syndrome. Neurogastroenterology & Motility 2024; 36(1) doi: 10.1111/nmo.14641
182
Andrea S. Shin, Xiang Gao, Matthew Bohm, Huaiying Lin, Anita Gupta, David E. Nelson, Evelyn Toh, Sean Teagarden, Robert Siwiec, Qunfeng Dong, John M. Wo. Characterization of Proximal Small Intestinal Microbiota in Patients With Suspected Small Intestinal Bacterial Overgrowth: A Cross-Sectional Study. Clinical and Translational Gastroenterology 2019; 10(8): e00073 doi: 10.14309/ctg.0000000000000073
183
I. M. Carroll, T. Ringel‐Kulka, J. P. Siddle, Y. Ringel. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea‐predominant irritable bowel syndrome. Neurogastroenterology & Motility 2012; 24(6): 521 doi: 10.1111/j.1365-2982.2012.01891.x
184
Ioana-Miruna Balmus, Ovidiu-Dumitru Ilie, Alin Ciobica, Roxana-Oana Cojocariu, Carol Stanciu, Anca Trifan, Mirela Cimpeanu, Cristian Cimpeanu, Lucian Gorgan. Irritable Bowel Syndrome between Molecular Approach and Clinical Expertise—Searching for Gap Fillers in the Oxidative Stress Way of Thinking. Medicina 2020; 56(1): 38 doi: 10.3390/medicina56010038
185
Elsa Sandberg Nielsen, Eirik Garnås, Kathrine Juul Jensen, Lars Hestbjerg Hansen, Peder Sandvold Olsen, Christian Ritz, Lukasz Krych, Dennis Sandris Nielsen. Lacto-fermented sauerkraut improves symptoms in IBS patients independent of product pasteurisation – a pilot study. Food & Function 2018; 9(10): 5323 doi: 10.1039/C8FO00968F
186
Ian M Carroll, Young-Hyo Chang, Jiwon Park, R Balfour Sartor, Yehuda Ringel. Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Gut Pathogens 2010; 2(1) doi: 10.1186/1757-4749-2-19
187
Mirjana Rajilić–Stojanović, Elena Biagi, Hans G.H.J. Heilig, Kajsa Kajander, Riina A. Kekkonen, Sebastian Tims, Willem M. de Vos. Global and Deep Molecular Analysis of Microbiota Signatures in Fecal Samples From Patients With Irritable Bowel Syndrome. Gastroenterology 2011; 141(5): 1792 doi: 10.1053/j.gastro.2011.07.043
188
Anna M. Plantinga, Kendra J. Kamp, Qinglong Wu, Li Chen, Linda Yoo, Robert L. Burr, Kevin C. Cain, Daniel Raftery, Fausto Carnevale Neto, Shyam Badu, Sik Yu So, Tor Savidge, Robert J. Shulman, Margaret M. Heitkemper. Exploration of associations among dietary tryptophan, microbiome composition and function, and symptom severity in irritable bowel syndrome. Neurogastroenterology & Motility 2023; 35(5) doi: 10.1111/nmo.14545
189
Max Schmulson, María Victoria Bielsa, Ramón Carmona-Sánchez, Angélica Hernández, Aurelio López-Colombo, Yolanda López Vidal, Mario Peláez-Luna, José María Remes-Troche, José Luis Tamayo, Miguel Angel Valdovinos. Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome (IBS): an evidence-based review. Revista de Gastroenterología de México (English Edition) 2014; 79(2): 96 doi: 10.1016/j.rgmxen.2014.01.001
190
Aldona Dlugosz, Björn Winckler, Elin Lundin, Katherina Zakikhany, Gunnar Sandström, Weimin Ye, Lars Engstrand, Greger Lindberg. No difference in small bowel microbiota between patients with irritable bowel syndrome and healthy controls. Scientific Reports 2015; 5(1) doi: 10.1038/srep08508
191
D. M. Pinn, O. C. Aroniadis, L. J. Brandt. Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)?. Neurogastroenterology & Motility 2015; 27(1): 19 doi: 10.1111/nmo.12479
192
Mengsi Zhou, Xiaoya Li, Xuehong Wang, Na Deng, Ying Cai, Zhoujin Tan. The dysfunction in intestinal microorganisms and enzyme activity as significant contributors to diarrhea with kidney-yang deficiency syndrome. Frontiers in Microbiology 2024; 14 doi: 10.3389/fmicb.2023.1324938
193
Peter A. Dobranowski, Alain Stintzi. Resistant starch, microbiome, and precision modulation. Gut Microbes 2021; 13(1) doi: 10.1080/19490976.2021.1926842
194
Vassilia Theodorou, Afifa Ait-Belgnaoui, Simona Agostini, Helene Eutamene. Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome. Gut Microbes 2014; 5(3): 430 doi: 10.4161/gmic.29796
195
Yogesh Bhattarai, David A. Muniz Pedrogo, Purna C. Kashyap. Irritable bowel syndrome: a gut microbiota-related disorder?. American Journal of Physiology-Gastrointestinal and Liver Physiology 2017; 312(1): G52 doi: 10.1152/ajpgi.00338.2016
196
Ruchi Mathur, Gillian M Barlow. Obesity and the microbiome. Expert Review of Gastroenterology & Hepatology 2015; 9(8): 1087 doi: 10.1586/17474124.2015.1051029
197
Gertjan Schaafsma, Joanne L. Slavin. Significance of Inulin Fructans in the Human Diet. Comprehensive Reviews in Food Science and Food Safety 2015; 14(1): 37 doi: 10.1111/1541-4337.12119
198
Nima Mohammadzadeh, Behrooz Sadeghi Kalani, Shahin Bolori, Azadeh Azadegan, Afsaneh Gholami, Rokhsareh Mohammadzadeh, Faramarz Masjedian Jazi. Identification of an intestinal microbiota signature associated with hospitalized patients with diarrhea. Acta Microbiologica et Immunologica Hungarica 2019; 66(2): 189 doi: 10.1556/030.66.2019.002
199
P. Layer, V. Andresen, H. Allescher, S. C. Bischoff, M. Claßen, S. Elsenbruch, M. Freitag, T. Frieling, M. Gebhard, M. Goebel-Stengel, W. Häuser, G. Holtmann, J. Keller, M. E. Kreis, W. Kruis, J. Langhorst, P. Lynen Jansen, A. Madisch, H. Mönnikes, S. Müller-Lissner, B. Niesler, C. Pehl, D. Pohl, M. Raithel, G. Röhrig-Herzog, M. Schemann, S. Schmiedel, J. Schwille-Kiuntke, M. Storr, J. C. Preiß, T. Andus, S. Buderus, U. Ehlert, M. Engel, A. Enninger, W. Fischbach, A. Gillessen, J. Gschossmann, F. Gundling, S. Haag, U. Helwig, S. Hollerbach, M. Karaus, M. Katschinski, H. Krammer, R. Kuhlbusch-Zicklam, H. Matthes, D. Menge, S. Miehlke, M. C. Posovszky, R. Schaefert, A. Schmidt-Choudhury, O. Schwandner, A. Schweinlin, H. Seidl, A. Stengel, J. Tesarz, I. van der Voort, W. Voderholzer, G. von Boyen, J. von Schönfeld, T. Wedel. Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016. Zeitschrift für Gastroenterologie 2021; 59(12): 1323 doi: 10.1055/a-1591-4794
200
Giada De Palma, Stephen M Collins, Premysl Bercik. The microbiota-gut-brain axis in functional gastrointestinal disorders. Gut Microbes 2014; 5(3): 419 doi: 10.4161/gmic.29417
201
Gillian M. Barlow, Eugenia A. Lin, Ruchi Mathur. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome. 2018; : 65 doi: 10.1016/B978-0-12-812019-4.00006-4
202
Johanna S. Bobardt, Michael H. Freitag. Das Reizdarmsyndrom in der hausärztlichen Praxis. Zeitschrift für Allgemeinmedizin 2023; 99(2): 97 doi: 10.1007/s44266-023-00023-5
203
Lucas Wauters, Nicholas J Talley, Marjorie M Walker, Jan Tack, Tim Vanuytsel. Novel concepts in the pathophysiology and treatment of functional dyspepsia. Gut 2020; 69(3): 591 doi: 10.1136/gutjnl-2019-318536
204
Yu. V. Bukina, N. N. Polishchuk, H. V. Bachurin, O. S. Cherkovska, O. L. Zinych, O. L. Lazaryk, M. B. Bezugly. Salmonella-induced changes of the rat intestinal microbiota. Russian Journal of Infection and Immunity 2021; 11(5): 865 doi: 10.15789/2220-7619-SIC-1507
205
Min Xu, Baohong Wang, Yiqi Fu, Yanfei Chen, Fengling Yang, Haifeng Lu, Yunbo Chen, Jiali Xu, Lanjuan Li. Changes of Fecal Bifidobacterium Species in Adult Patients with Hepatitis B Virus-Induced Chronic Liver Disease. Microbial Ecology 2012; 63(2): 304 doi: 10.1007/s00248-011-9925-5
206
Nicholas J. Talley, Gerald Holtmann, Marjorie M. Walker. Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology. Journal of Gastroenterology 2015; 50(6): 601 doi: 10.1007/s00535-015-1076-x
207
Marcel Roberfroid, Glenn R. Gibson, Lesley Hoyles, Anne L. McCartney, Robert Rastall, Ian Rowland, Danielle Wolvers, Bernhard Watzl, Hania Szajewska, Bernd Stahl, Francisco Guarner, Frederique Respondek, Kevin Whelan, Veronique Coxam, Marie-Jeanne Davicco, Laurent Léotoing, Yohann Wittrant, Nathalie M. Delzenne, Patrice D. Cani, Audrey M. Neyrinck, Agnes Meheust. Prebiotic effects: metabolic and health benefits. British Journal of Nutrition 2010; 104(S2): S1 doi: 10.1017/S0007114510003363
208
Antonia Piazzesi, Lorenza Putignani. Extremely small and incredibly close: Gut microbes as modulators of inflammation and targets for therapeutic intervention. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.958346
209
Jonathan P. Jacobs, Tien S. Dong, Vatche Agopian, Venu Lagishetty, Vinay Sundaram, Mazen Noureddin, Walid S. Ayoub, Francisco Durazo, Jihane Benhammou, Pedram Enayati, David Elashoff, Marc T. Goodman, Joseph Pisegna, Shehnaz Hussain. Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study. Hepatology Research 2018; 48(13): 1108 doi: 10.1111/hepr.13207
210
Valerio Mezzasalma, Enrico Manfrini, Emanuele Ferri, Anna Sandionigi, Barbara La Ferla, Irene Schiano, Angela Michelotti, Vincenzo Nobile, Massimo Labra, Patrizia Di Gennaro. A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/4740907
211
Mark Pimentel, Gillian M Barlow, Jae Hak Kim, Christopher Chang. Autoimmunity and Irritable Bowel Syndrome: New Pathophysiology. The American Journal of Gastroenterology Supplements 2016; 3(2): 41 doi: 10.1038/ajgsup.2016.13
212
Gerard Clarke, Eamonn M.M. Quigley, John F. Cryan, Timothy G. Dinan. Irritable bowel syndrome: towards biomarker identification. Trends in Molecular Medicine 2009; 15(10): 478 doi: 10.1016/j.molmed.2009.08.001
213
Charlotte Pratt, Matthew D. Campbell. The Effect of Bifidobacterium on Reducing Symptomatic Abdominal Pain in Patients with Irritable Bowel Syndrome: A Systematic Review. Probiotics and Antimicrobial Proteins 2020; 12(3): 834 doi: 10.1007/s12602-019-09609-7
214
Hyun Deok Noh, Min Jeong Kim, Im Hak Cho, So Yeon Kim. Review on the Objective Effect and Mechanism Studies of Herbal Medicine, Acupuncture and Moxibustion Treatment for Irritable Bowel Syndrome Patients. Journal of Physiology & Pathology in Korean Medicine 2021; 35(5): 199 doi: 10.15188/kjopp.2021.10.35.5.199
215
Shi-Lian Li, Shao-Qin Zheng, Ying-Zi Tang, Hui-Min Liu, Qing Mao. Progress in understanding of relationship between duodenal mucosal microecology and hepatitis B virus related acute-on-chronic liver failure. World Chinese Journal of Digestology 2022; 30(24): 1074 doi: 10.11569/wcjd.v30.i24.1074
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
216
Anita Gąsiorowska, Marek Romanowski, Ewa Walecka-Kapica, Aleksandra Kaczka, Cezary Chojnacki, Milena Padysz, Marta Siedlecka, Joanna B. Bierła, Robert E. Steinert, Bożena Cukrowska. Effects of Microencapsulated Sodium Butyrate, Probiotics and Short Chain Fructooligosaccharides in Patients with Irritable Bowel Syndrome: A Study Protocol of a Randomized Double-Blind Placebo-Controlled Trial. Journal of Clinical Medicine 2022; 11(21): 6587 doi: 10.3390/jcm11216587
217
Xiaojun Zhuang, Lishou Xiong, Li Li, Manying Li, Minhu Chen. Alterations of gut microbiota in patients with irritable bowel syndrome: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 2017; 32(1): 28 doi: 10.1111/jgh.13471
218
Elizabeth J. Videlock, Lin Chang. Yamada' s Textbook of Gastroenterology. 2015; : 1495 doi: 10.1002/9781118512074.ch75
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345